Status: current, Defined. Date: 31-Jul 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4837131000168119 | Hyoscine Butylbromide (AFT) (hyoscine butylbromide 20 mg / 1 mL) injection, 5 x 1 mL ampoules (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4837141000168111 | Hyoscine Butylbromide (AFT) 20 mg/mL injection, 5 x 1 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Hyoscine Butylbromide (AFT) 20 mg/mL injection, 5 x 1 mL ampoules | Is a | hyoscine butylbromide 20 mg/mL injection, 5 x 1 mL ampoules | true | Inferred relationship | Some | ||
| Hyoscine Butylbromide (AFT) 20 mg/mL injection, 5 x 1 mL ampoules | Is a | trade product pack | true | Inferred relationship | Some | ||
| Hyoscine Butylbromide (AFT) 20 mg/mL injection, 5 x 1 mL ampoules | has TP | Hyoscine Butylbromide (AFT) | true | Inferred relationship | Some | ||
| Hyoscine Butylbromide (AFT) 20 mg/mL injection, 5 x 1 mL ampoules | has TPUU | Hyoscine Butylbromide (AFT) 20 mg/mL injection, 1 mL ampoule | true | Inferred relationship | Some | 1129334620 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Hyoscine Butylbromide (AFT) 20 mg/mL injection, 5 x 1 mL ampoules | Is a | True | Hyoscine Butylbromide (AFT) 20 mg/mL injection, 5 x 1 mL ampoules | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR